C4 Therapeutics, Inc. · NASDAQ:CCCC

Point72 Asset Management, L.P. reported a 9.90% stake in C4 Therapeutics, Inc. (Schedule 13G)

Event Oct 17, 2025 · Filed Oct 20, 2025

Point72 Asset Management, L.P. reported a 9.90% stake in C4 Therapeutics, Inc., 22,647,647 shares, as a passive investor on Oct 17, 2025. Filed Oct 20, 2025 (Schedule 13G).

Stake
9.90%
Shares
22,647,647
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Point72 Asset Management, L.P.9.90%22,647,647
Point72 Capital Advisors, Inc.9.90%22,647,647
Steven A. Cohen9.90%22,647,647

Source

View original at SEC

Related